StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

Equities research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Tuesday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Price Performance

Shares of MLSS opened at $0.58 on Tuesday. The firm has a market cap of $44.25 million, a P/E ratio of -5.78 and a beta of 0.98. The stock has a 50 day simple moving average of $0.67 and a two-hundred day simple moving average of $0.72. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35.

Milestone Scientific (NYSE:MLSS) last issued its earnings results on Friday, March 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%. The firm had revenue of $2.26 million during the quarter.

Institutional Trading of Milestone Scientific

Hedge funds and other institutional investors have recently bought and sold shares of the stock. AE Wealth Management LLC bought a new position in shares of Milestone Scientific during the third quarter valued at approximately $26,000. Charles Schwab Investment Management Inc. bought a new position in shares of Milestone Scientific during the second quarter valued at approximately $30,000. Royal Bank of Canada bought a new position in shares of Milestone Scientific during the first quarter valued at approximately $30,000. Virtu Financial LLC raised its holdings in shares of Milestone Scientific by 370.1% during the fourth quarter. Virtu Financial LLC now owns 67,265 shares of the company’s stock valued at $32,000 after acquiring an additional 52,957 shares in the last quarter. Finally, Jane Street Group LLC bought a new position in shares of Milestone Scientific during the first quarter valued at approximately $35,000. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical.